Written by Peter J. Pitts Hedge fund investors are coming to raid your medicine cabinet. Cutting-edge treatments for diseases affecting millions of Americans are threatened by Wall Street’s latest moneymaking scheme. In their ploy, hedge funds bet against a drug company’s stock price, launch attacks against the firm’s patents on its best-selling medicines, and then … Continue reading Congress must protect vital drug patents from Wall Street’s inter partes review attacks